Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Orgenesis adopts stem cells with MaSTherCell

The American company Orgenesis obtained MaSTherCell (Gosselies) for $24.6 million. Enterpreneur Hugues Bultot’s MaSTherCell specializes in the p…

POPULAR TAGS

Mithra to become the new Omega Pharma?

Written by DS on in the category quick facts with the tags .


Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, behind his Walloon counterpart, CEO François Fornieri. Coucke was  appointed as chairman of the Strategic Committee of Mithra Pharmaceuticals on January 26th, to prepare the IPO of the company.  The money will be invested in the R&D activities of the group. The company's showpiece is the contraceptive pill Estelle, based on the natural hormone esterol.

Read more about: .

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Orgenesis adopts stem cells with MaSTherCell

The American company Orgenesis obtained MaSTherCell (Gosselies) for $24.6 million. Enterpreneur Hugues Bultot’s MaSTherCell specializes in the p…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

KU Leuven GSK UGent Turnstone Biowin Itera Life Science XpandInnovation V-Bio Ventures Janssen Flanders.bio

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.